West Nile Virus (WNV) is an emerging mosquito-borne human and animal pathogen that has caused Ioutbreaks of fatal encephalitis in Europe, Asia, the Middle East, and most recently, the United States.Little is known about the pathogenesis of WNV infection and the immune system response that preventsextension into the central nervous system (CNS) in most hosts. Recently, using a mouse model of WNVencephalitis, we have demonstrated that a deficiency of antibody or complement proteins leads to adisseminated, fatal infection. Based on these observations, the proposed research plans to directlydetermine how B cells, antibody and complement orchestrate a protective immune response against WNV.
In Specific Aim 1, our in vivo mouse model of WNV infection will be used to determine the protective roleof natural and specific IgM against WNV in limiting the early phase of dissemination and the subset of Bcells that mediate this response.
In Specific Aim 2, the mechanism by which complement primes theadaptive immune response against WNV will be characterized.
In Specific Aim 3, the role andmechanism by which complement receptor 1 and 2 trigger adaptive immunity against WNV will beinvestigated. The identification of specific mechanisms for controlling early dissemination of WNV infectionand triggering long-term protection will enhance our understanding of viral pathogenesis and theepidemiology of WNV-induced disease, and possibly provide a rationale for therapeutic intervention.
Showing the most recent 10 out of 338 publications
